Resultados de la búsqueda 191-200 de 22191 para biopsy

  1. La salud de adolescentes y preadolescentes - Mayo Clinic

    News · julio 2024 · junio 2024 · mayo 2024 · abril 2024 · marzo 2024 · febrero 2024 · enero 2024 · diciembre 2023.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  3. Neurología - Ensayos clínicos - Mayo Clinic

    To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...

  4. Cirugía cerebral con el paciente despierto para el glioma: la historia de Kay - Mayo Clinic

    Thumbnail for Biopsy confirms rare form of multiple sclerosis: Lucas' story. Biopsy confirms rare form of multiple sclerosis: Lucas' story. 2:44.

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine how well cisplatin and combination chemotherapy works in treating children and young adults with hepatoblastoma or ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, ...

  8. Clinical Genomics - Ensayos clínicos

    Mayo Clinic Clinical Genomics uses genomic testing to develop knowledge about a person's DNA to help predict, prevent, diagnose and treat disease.

  9. Oncología (médica) - Ensayos clínicos

    Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors. Rochester, Minn. The purpose of this study is to evaluate ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...